Literature DB >> 25192732

Are we lacking economic evaluations in gastric cancer treatment?

Alyson L Mahar1, Abraham El-Sedfy, Savtaj S Brar, Ana Johnson, Natalie Coburn.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25192732     DOI: 10.1007/s40273-014-0215-1

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  27 in total

1.  Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer.

Authors:  Bo Hultman; Jonas Lundkvist; Bengt Glimelius; Peter Nygren; Haile Mahteme
Journal:  Acta Oncol       Date:  2011-11-10       Impact factor: 4.089

2.  Profiling of resource use variation among six diseases treated at 82 Japanese special functioning hospitals, based on administrative data.

Authors:  Kazuaki Kuwabara; Yuichi Imanaka; Shinya Matsuda; Kiyohide Fushimi; Hideki Hashimoto; Koichi B Ishikawa; Hiromasa Horiguchi
Journal:  Health Policy       Date:  2005-12-15       Impact factor: 2.980

3.  Influence of Japan's new Diagnosis Procedure Combination-based payment system on the surgical sector: does it really shorten the hospital stay?

Authors:  Hideo Yasunaga; Hiroo Ide; Tomoaki Imamura; Kazukiko Ohe
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

5.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

6.  Laparoscopy-assisted and open distal gastrectomies for early gastric cancer at a general hospital in Japan.

Authors:  Takuji Naka; Takanori Ishikura; Syunsuke Shibata; Yumi Yamaguchi; Minoru Ishiguro; Eiichi Yurugi; Hideaki Nishidoi; Hirofumi Kudoh; Satoshi Murakami; Shunichi Tsujitani
Journal:  Hepatogastroenterology       Date:  2005 Jan-Feb

7.  Gasless laparoscopy-assisted distal gastrectomy for early gastric cancer: analysis of initial results.

Authors:  Tung-Cheng Chang; Chien-Chia Chen; Ming-Yang Wang; Ching-Yao Yang; Ming-Tsan Lin
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2011-01-23       Impact factor: 1.878

8.  High-quality, low-cost gastrectomy care at high-volume hospitals: results from a population-based study in South Korea.

Authors:  Jung A Lee; Jong Hyock Park; Eun Jung Lee; So Young Kim; Yoon Kim; Sang Il Lee
Journal:  Arch Surg       Date:  2011-04-18

9.  Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study.

Authors:  Claire de Oliveira; Karen E Bremner; Reka Pataky; Nadia Gunraj; Kelvin Chan; Stuart Peacock; Murray D Krahn
Journal:  CMAJ Open       Date:  2013-01-16

10.  Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel.

Authors:  Savtaj S Brar; Alyson L Mahar; Lucy K Helyer; Carol Swallow; Calvin Law; Lawrence Paszat; Rajini Seevaratnam; Roberta Cardoso; Robin McLeod; Matthew Dixon; Lavanya Yohanathan; Laercio G Lourenco; Alina Bocicariu; Tanios Bekaii-Saab; Ian Chau; Neal Church; Daniel Coit; Christopher H Crane; Craig Earle; Paul Mansfield; Norman Marcon; Thomas Miner; Sung Hoon Noh; Geoff Porter; Mitchell C Posner; Vivek Prachand; Takeshi Sano; Cornelis van de Velde; Sandra Wong; Natalie G Coburn
Journal:  JAMA Surg       Date:  2014-01       Impact factor: 14.766

View more
  4 in total

1.  Regional variation in the management of metastatic gastric cancer in Ontario.

Authors:  A L Mahar; N G Coburn; D J Kagedan; R Viola; A P Johnson
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

2.  Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis.

Authors:  Julie Hallet; Nicole J Look Hong; Victoria Zuk; Laura E Davis; Vaibhav Gupta; Craig C Earle; Nicole Mittmann; Natalie G Coburn
Journal:  Gastric Cancer       Date:  2019-12-13       Impact factor: 7.370

3.  Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study.

Authors:  Franz Castro; David Shahal; Musharaf Tarajia; Ilais Moreno Velásquez; Maribel Tribaldos Causadias; Víctor Herrera; Beatriz Gómez; Moisés Cukier; Jorge Motta
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

4.  Economic cost-utility analysis of stage-directed gastric cancer treatment.

Authors:  Arfon G Powell; Jennifer R Wheat; Catherine Eley; David Robinson; Stuart A Roberts; Wyn Lewis
Journal:  BJS Open       Date:  2021-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.